Combinatorial synthesis of CCR5 antagonists

Herein we report the preparation of a combinatorial library of compounds with potent CCR5 binding affinity. The library design was aided by SAR generated in a traditional medicinal chemistry effort. Compounds with novel combinations of subunits were discovered that have high binding affinity for the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioorganic & medicinal chemistry letters 2001-12, Vol.11 (24), p.3137-3141
Hauptverfasser: Willoughby, Christopher A, Berk, Scott C, Rosauer, Keith G, Degrado, Silvia, Chapman, Kevin T, Gould, Sandra L, Springer, Martin S, Malkowitz, Lorraine, Schleif, William A, Hazuda, Daria, Miller, Michael, Kessler, Joseph, Danzeisen, Renee, Holmes, Karen, Lineberger, Janet, Carella, Anthony, Carver, Gwen, Emini, Emilio A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3141
container_issue 24
container_start_page 3137
container_title Bioorganic & medicinal chemistry letters
container_volume 11
creator Willoughby, Christopher A
Berk, Scott C
Rosauer, Keith G
Degrado, Silvia
Chapman, Kevin T
Gould, Sandra L
Springer, Martin S
Malkowitz, Lorraine
Schleif, William A
Hazuda, Daria
Miller, Michael
Kessler, Joseph
Danzeisen, Renee
Holmes, Karen
Lineberger, Janet
Carella, Anthony
Carver, Gwen
Emini, Emilio A
description Herein we report the preparation of a combinatorial library of compounds with potent CCR5 binding affinity. The library design was aided by SAR generated in a traditional medicinal chemistry effort. Compounds with novel combinations of subunits were discovered that have high binding affinity for the CCR5 receptor. A potent CCR5 antagonist from the library, compound 11 was found to have moderate anti-HIV-1 activity. The synthesis of the combinatorial library of CCR5 antagonists is reported. Compound 2 was discovered, which has a 1 nM IC 50 in a CCR5 binding assay and inhibits HIV-1 replication with an IC 95 of 580 nM.
doi_str_mv 10.1016/S0960-894X(01)00652-7
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72303492</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0960894X01006527</els_id><sourcerecordid>72303492</sourcerecordid><originalsourceid>FETCH-LOGICAL-c391t-fe3ef7a9f68543d410a07dcdfed62de1ecdbe536467ac81a5bc8509b4ab790f13</originalsourceid><addsrcrecordid>eNqFkEtLxDAUhYMozjj6E5TZKIpU723TtF2JFF8wIPgAdyFNbjTSaTXpCPPv7Txwlq7u5jvnHj7GDhEuEFBcPkMhIMoL_nYKeAYg0jjKttgQueBRwiHdZsM_ZMD2QvgEQA6c77IBYhZDLmDIzst2WrlGda13qh6HedN9UHBh3NpxWT6lY9V06r1tXOjCPtuxqg50sL4j9np781LeR5PHu4fyehLppMAuspSQzVRhRZ7yxHAEBZnRxpIRsSEkbSpKE8FFpnSOKq10nkJRcVVlBVhMRuxk1fvl2-8ZhU5OXdBU16qhdhZkFieQ8CLuwXQFat-G4MnKL--mys8lglxYkktLcqFAAsqlJZn1uaP1g1k1JbNJrbX0wPEaUEGr2nrVaBc2HEfMRb4YcLXiqNfx48jLoB01mozzpDtpWvfPlF8bNIPV</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72303492</pqid></control><display><type>article</type><title>Combinatorial synthesis of CCR5 antagonists</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Willoughby, Christopher A ; Berk, Scott C ; Rosauer, Keith G ; Degrado, Silvia ; Chapman, Kevin T ; Gould, Sandra L ; Springer, Martin S ; Malkowitz, Lorraine ; Schleif, William A ; Hazuda, Daria ; Miller, Michael ; Kessler, Joseph ; Danzeisen, Renee ; Holmes, Karen ; Lineberger, Janet ; Carella, Anthony ; Carver, Gwen ; Emini, Emilio A</creator><creatorcontrib>Willoughby, Christopher A ; Berk, Scott C ; Rosauer, Keith G ; Degrado, Silvia ; Chapman, Kevin T ; Gould, Sandra L ; Springer, Martin S ; Malkowitz, Lorraine ; Schleif, William A ; Hazuda, Daria ; Miller, Michael ; Kessler, Joseph ; Danzeisen, Renee ; Holmes, Karen ; Lineberger, Janet ; Carella, Anthony ; Carver, Gwen ; Emini, Emilio A</creatorcontrib><description>Herein we report the preparation of a combinatorial library of compounds with potent CCR5 binding affinity. The library design was aided by SAR generated in a traditional medicinal chemistry effort. Compounds with novel combinations of subunits were discovered that have high binding affinity for the CCR5 receptor. A potent CCR5 antagonist from the library, compound 11 was found to have moderate anti-HIV-1 activity. The synthesis of the combinatorial library of CCR5 antagonists is reported. Compound 2 was discovered, which has a 1 nM IC 50 in a CCR5 binding assay and inhibits HIV-1 replication with an IC 95 of 580 nM.</description><identifier>ISSN: 0960-894X</identifier><identifier>EISSN: 1464-3405</identifier><identifier>DOI: 10.1016/S0960-894X(01)00652-7</identifier><identifier>PMID: 11720860</identifier><language>eng</language><publisher>Oxford: Elsevier Ltd</publisher><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents ; Antiviral agents ; Biological and medical sciences ; CCR5 Receptor Antagonists ; Combinatorial Chemistry Techniques ; HIV-1 - drug effects ; Medical sciences ; Pharmacology. Drug treatments ; Structure-Activity Relationship</subject><ispartof>Bioorganic &amp; medicinal chemistry letters, 2001-12, Vol.11 (24), p.3137-3141</ispartof><rights>2001 Elsevier Science Ltd</rights><rights>2002 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c391t-fe3ef7a9f68543d410a07dcdfed62de1ecdbe536467ac81a5bc8509b4ab790f13</citedby><cites>FETCH-LOGICAL-c391t-fe3ef7a9f68543d410a07dcdfed62de1ecdbe536467ac81a5bc8509b4ab790f13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0960-894X(01)00652-7$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=14118682$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11720860$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Willoughby, Christopher A</creatorcontrib><creatorcontrib>Berk, Scott C</creatorcontrib><creatorcontrib>Rosauer, Keith G</creatorcontrib><creatorcontrib>Degrado, Silvia</creatorcontrib><creatorcontrib>Chapman, Kevin T</creatorcontrib><creatorcontrib>Gould, Sandra L</creatorcontrib><creatorcontrib>Springer, Martin S</creatorcontrib><creatorcontrib>Malkowitz, Lorraine</creatorcontrib><creatorcontrib>Schleif, William A</creatorcontrib><creatorcontrib>Hazuda, Daria</creatorcontrib><creatorcontrib>Miller, Michael</creatorcontrib><creatorcontrib>Kessler, Joseph</creatorcontrib><creatorcontrib>Danzeisen, Renee</creatorcontrib><creatorcontrib>Holmes, Karen</creatorcontrib><creatorcontrib>Lineberger, Janet</creatorcontrib><creatorcontrib>Carella, Anthony</creatorcontrib><creatorcontrib>Carver, Gwen</creatorcontrib><creatorcontrib>Emini, Emilio A</creatorcontrib><title>Combinatorial synthesis of CCR5 antagonists</title><title>Bioorganic &amp; medicinal chemistry letters</title><addtitle>Bioorg Med Chem Lett</addtitle><description>Herein we report the preparation of a combinatorial library of compounds with potent CCR5 binding affinity. The library design was aided by SAR generated in a traditional medicinal chemistry effort. Compounds with novel combinations of subunits were discovered that have high binding affinity for the CCR5 receptor. A potent CCR5 antagonist from the library, compound 11 was found to have moderate anti-HIV-1 activity. The synthesis of the combinatorial library of CCR5 antagonists is reported. Compound 2 was discovered, which has a 1 nM IC 50 in a CCR5 binding assay and inhibits HIV-1 replication with an IC 95 of 580 nM.</description><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Antiviral agents</subject><subject>Biological and medical sciences</subject><subject>CCR5 Receptor Antagonists</subject><subject>Combinatorial Chemistry Techniques</subject><subject>HIV-1 - drug effects</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><subject>Structure-Activity Relationship</subject><issn>0960-894X</issn><issn>1464-3405</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkEtLxDAUhYMozjj6E5TZKIpU723TtF2JFF8wIPgAdyFNbjTSaTXpCPPv7Txwlq7u5jvnHj7GDhEuEFBcPkMhIMoL_nYKeAYg0jjKttgQueBRwiHdZsM_ZMD2QvgEQA6c77IBYhZDLmDIzst2WrlGda13qh6HedN9UHBh3NpxWT6lY9V06r1tXOjCPtuxqg50sL4j9np781LeR5PHu4fyehLppMAuspSQzVRhRZ7yxHAEBZnRxpIRsSEkbSpKE8FFpnSOKq10nkJRcVVlBVhMRuxk1fvl2-8ZhU5OXdBU16qhdhZkFieQ8CLuwXQFat-G4MnKL--mys8lglxYkktLcqFAAsqlJZn1uaP1g1k1JbNJrbX0wPEaUEGr2nrVaBc2HEfMRb4YcLXiqNfx48jLoB01mozzpDtpWvfPlF8bNIPV</recordid><startdate>20011217</startdate><enddate>20011217</enddate><creator>Willoughby, Christopher A</creator><creator>Berk, Scott C</creator><creator>Rosauer, Keith G</creator><creator>Degrado, Silvia</creator><creator>Chapman, Kevin T</creator><creator>Gould, Sandra L</creator><creator>Springer, Martin S</creator><creator>Malkowitz, Lorraine</creator><creator>Schleif, William A</creator><creator>Hazuda, Daria</creator><creator>Miller, Michael</creator><creator>Kessler, Joseph</creator><creator>Danzeisen, Renee</creator><creator>Holmes, Karen</creator><creator>Lineberger, Janet</creator><creator>Carella, Anthony</creator><creator>Carver, Gwen</creator><creator>Emini, Emilio A</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20011217</creationdate><title>Combinatorial synthesis of CCR5 antagonists</title><author>Willoughby, Christopher A ; Berk, Scott C ; Rosauer, Keith G ; Degrado, Silvia ; Chapman, Kevin T ; Gould, Sandra L ; Springer, Martin S ; Malkowitz, Lorraine ; Schleif, William A ; Hazuda, Daria ; Miller, Michael ; Kessler, Joseph ; Danzeisen, Renee ; Holmes, Karen ; Lineberger, Janet ; Carella, Anthony ; Carver, Gwen ; Emini, Emilio A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c391t-fe3ef7a9f68543d410a07dcdfed62de1ecdbe536467ac81a5bc8509b4ab790f13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Antiviral agents</topic><topic>Biological and medical sciences</topic><topic>CCR5 Receptor Antagonists</topic><topic>Combinatorial Chemistry Techniques</topic><topic>HIV-1 - drug effects</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><topic>Structure-Activity Relationship</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Willoughby, Christopher A</creatorcontrib><creatorcontrib>Berk, Scott C</creatorcontrib><creatorcontrib>Rosauer, Keith G</creatorcontrib><creatorcontrib>Degrado, Silvia</creatorcontrib><creatorcontrib>Chapman, Kevin T</creatorcontrib><creatorcontrib>Gould, Sandra L</creatorcontrib><creatorcontrib>Springer, Martin S</creatorcontrib><creatorcontrib>Malkowitz, Lorraine</creatorcontrib><creatorcontrib>Schleif, William A</creatorcontrib><creatorcontrib>Hazuda, Daria</creatorcontrib><creatorcontrib>Miller, Michael</creatorcontrib><creatorcontrib>Kessler, Joseph</creatorcontrib><creatorcontrib>Danzeisen, Renee</creatorcontrib><creatorcontrib>Holmes, Karen</creatorcontrib><creatorcontrib>Lineberger, Janet</creatorcontrib><creatorcontrib>Carella, Anthony</creatorcontrib><creatorcontrib>Carver, Gwen</creatorcontrib><creatorcontrib>Emini, Emilio A</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Bioorganic &amp; medicinal chemistry letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Willoughby, Christopher A</au><au>Berk, Scott C</au><au>Rosauer, Keith G</au><au>Degrado, Silvia</au><au>Chapman, Kevin T</au><au>Gould, Sandra L</au><au>Springer, Martin S</au><au>Malkowitz, Lorraine</au><au>Schleif, William A</au><au>Hazuda, Daria</au><au>Miller, Michael</au><au>Kessler, Joseph</au><au>Danzeisen, Renee</au><au>Holmes, Karen</au><au>Lineberger, Janet</au><au>Carella, Anthony</au><au>Carver, Gwen</au><au>Emini, Emilio A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Combinatorial synthesis of CCR5 antagonists</atitle><jtitle>Bioorganic &amp; medicinal chemistry letters</jtitle><addtitle>Bioorg Med Chem Lett</addtitle><date>2001-12-17</date><risdate>2001</risdate><volume>11</volume><issue>24</issue><spage>3137</spage><epage>3141</epage><pages>3137-3141</pages><issn>0960-894X</issn><eissn>1464-3405</eissn><abstract>Herein we report the preparation of a combinatorial library of compounds with potent CCR5 binding affinity. The library design was aided by SAR generated in a traditional medicinal chemistry effort. Compounds with novel combinations of subunits were discovered that have high binding affinity for the CCR5 receptor. A potent CCR5 antagonist from the library, compound 11 was found to have moderate anti-HIV-1 activity. The synthesis of the combinatorial library of CCR5 antagonists is reported. Compound 2 was discovered, which has a 1 nM IC 50 in a CCR5 binding assay and inhibits HIV-1 replication with an IC 95 of 580 nM.</abstract><cop>Oxford</cop><pub>Elsevier Ltd</pub><pmid>11720860</pmid><doi>10.1016/S0960-894X(01)00652-7</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0960-894X
ispartof Bioorganic & medicinal chemistry letters, 2001-12, Vol.11 (24), p.3137-3141
issn 0960-894X
1464-3405
language eng
recordid cdi_proquest_miscellaneous_72303492
source MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects Antibiotics. Antiinfectious agents. Antiparasitic agents
Antiviral agents
Biological and medical sciences
CCR5 Receptor Antagonists
Combinatorial Chemistry Techniques
HIV-1 - drug effects
Medical sciences
Pharmacology. Drug treatments
Structure-Activity Relationship
title Combinatorial synthesis of CCR5 antagonists
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T21%3A31%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Combinatorial%20synthesis%20of%20CCR5%20antagonists&rft.jtitle=Bioorganic%20&%20medicinal%20chemistry%20letters&rft.au=Willoughby,%20Christopher%20A&rft.date=2001-12-17&rft.volume=11&rft.issue=24&rft.spage=3137&rft.epage=3141&rft.pages=3137-3141&rft.issn=0960-894X&rft.eissn=1464-3405&rft_id=info:doi/10.1016/S0960-894X(01)00652-7&rft_dat=%3Cproquest_cross%3E72303492%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72303492&rft_id=info:pmid/11720860&rft_els_id=S0960894X01006527&rfr_iscdi=true